The global vascular stents market has witnessed significant growth, with the market size reaching a value of nearly USD 10.57 billion in 2023. The vascular stents industry is poised for continued expansion, projected to grow at a compound annual growth rate (CAGR) of 5.5% from 2024 to 2032, ultimately reaching an estimated value of USD 17.10 billion by 2032. This growth trajectory reflects the increasing prevalence of cardiovascular diseases, advancements in stent technologies, and the growing global healthcare infrastructure.

Vascular stents are medical devices used to treat narrow or weakened arteries, ensuring blood flow through constricted vessels. These devices play a critical role in treating a variety of cardiovascular conditions, including coronary artery disease, peripheral artery disease, and carotid artery disease. The market for vascular stents is highly dynamic, influenced by technological advancements, regulatory factors, and a rising patient population. This blog post explores the various aspects of the vascular stents market, from its segments and trends to the key players and COVID-19's impact on the industry.

Key Players in the Global Vascular Stents Market

The vascular stents market is highly competitive, with several leading players dominating the industry. These companies offer a range of products, including bare-metal stents (BMS), drug-eluting stents (DES), bioresorbable stents, and other innovations. Some of the key players in the vascular stents market include:

1. Medtronic PLC
   Based in Dublin, Ireland, Medtronic is one of the world's largest medical device companies. Medtronic’s portfolio includes both coronary and peripheral vascular stents, with products like the Resolute Onyx Drug-Eluting Stent and Hercules Balloon-Expandable Stent. The company is also actively involved in the development of bioresorbable stents.

2. Abbott Laboratories
   Abbott, a global healthcare company headquartered in Illinois, USA, is known for its advanced vascular stent offerings. Abbott’s Xience Sierra Drug-Eluting Stent and Absorb Bioresorbable Vascular Scaffold are among the market leaders in coronary artery disease treatment.

3. Boston Scientific Corporation
   With its headquarters in Marlborough, Massachusetts, USA, Boston Scientific offers a variety of stents, including the Promus Element Plus and Synergy Stent. The company also focuses on developing innovative solutions, such as bioresorbable stents and drug-eluting stent technologies.

4. Johnson & Johnson
   Through its subsidiary, Cordis, Johnson & Johnson is a key player in the vascular stent market. The Cypher Stent and the Cobalt Stent are some of the notable products in its coronary stent portfolio.

5. Terumo Corporation
   Based in Tokyo, Japan, Terumo offers vascular stents under its Terumo Stent and Ultrathin Stent lines. The company is committed to advancing minimally invasive medical technologies for vascular interventions.

6. B. Braun Melsungen AG
   A leading German medical device company, B. Braun offers various products, including vascular stents used in the treatment of coronary artery diseases. B. Braun’s Avitene and Eclats Stent are well-regarded within the market.

These companies are continually innovating to improve the efficacy and safety of stents, investing in research and development to cater to the evolving needs of the healthcare sector.

Get a Free Sample Report with Table of Contents: https://www.expertmarketresearch.com/reports/vascular-stents-market/requestsample

Market Segmentation

The vascular stents market can be segmented by product type, application, end-user, and region. Understanding these segments helps stakeholders in the industry make informed decisions based on specific market dynamics.

1. Product Type

The vascular stents market is primarily divided into the following types:

• Bare-Metal Stents (BMS): These are the traditional form of vascular stents. While they are affordable and provide effective treatment, BMS are associated with a higher risk of restenosis (re-narrowing of the artery).
• Drug-Eluting Stents (DES): These stents are coated with medication that helps prevent restenosis by inhibiting the growth of scar tissue in the artery. DES has significantly improved patient outcomes in the treatment of coronary artery disease.
• Bioresorbable Stents: An emerging segment, bioresorbable stents are designed to dissolve after fulfilling their purpose of keeping the artery open. These are seen as a potential breakthrough in the field of cardiovascular interventions.

2. Application

The vascular stents market is segmented based on application, primarily:

• Coronary Artery Disease (CAD): This segment is the largest in the vascular stents market, as stents are widely used to treat CAD, a condition where the blood vessels supplying the heart become narrowed or blocked.
• Peripheral Artery Disease (PAD): Stents are also used in treating PAD, where the arteries outside the heart become narrowed, typically affecting the legs.
• Carotid Artery Disease (CAD): This involves stenting of the carotid arteries, which supply blood to the brain. This application is growing, especially with the rise in stroke prevention procedures.

3. End-User

The vascular stents market is segmented by end-users, which include:

• Hospitals
• Ambulatory Surgical Centres
• Specialty Clinics
• Cardiovascular Centres

Hospitals dominate this segment due to the high volume of vascular interventions performed in these settings.

4. Region

The vascular stents market is segmented into regions, which include:

• North America: Leading the market due to advanced healthcare infrastructure, high adoption of innovative medical technologies, and a large patient base.
• Europe: Strong growth due to an ageing population and an increasing number of cardiovascular disease cases.
• Asia-Pacific: The market is expanding rapidly due to increasing awareness, improving healthcare facilities, and a growing burden of cardiovascular diseases.
• Rest of the World (RoW): Emerging markets in Latin America, the Middle East, and Africa are contributing to market growth.

Market Outlook

The vascular stents market is expected to continue its upward trajectory in the coming years, driven by several key factors:

1. Rising Cardiovascular Diseases: Cardiovascular diseases (CVDs) are a leading cause of death globally. With the increasing prevalence of lifestyle-related risk factors such as hypertension, obesity, and smoking, the demand for stents is expected to rise steadily.

2. Technological Advancements: Continuous innovation in stent technology, such as drug-eluting stents, bioresorbable stents, and improvements in materials, is enhancing the effectiveness and safety of vascular interventions.

3. Increasing Geriatric Population: The global ageing population, particularly in developed regions, is contributing to an increased incidence of age-related cardiovascular conditions, which, in turn, boosts the demand for vascular stents.

4. Minimally Invasive Procedures: The growing preference for minimally invasive surgeries, which involve fewer complications and shorter recovery times, is boosting the adoption of vascular stents.

Market Trends

Several trends are shaping the future of the vascular stents market, including:

1. Rise in Minimally Invasive Procedures: There is an increasing preference for minimally invasive surgeries due to their associated benefits, including shorter hospital stays, reduced risk of infection, and quicker recovery times. This trend is driving the demand for vascular stents, which are integral to these procedures.

2. Innovation in Drug-Eluting Stents: Drug-eluting stents (DES) have revolutionized the treatment of coronary artery disease. Manufacturers are focusing on further improving these stents by developing new drugs with fewer side effects and improved long-term outcomes.

3. Bioresorbable Stents: Bioabsorbable or bioresorbable stents, which dissolve over time, are becoming an area of active research and development. These stents are expected to reduce the long-term complications associated with traditional metallic stents.

4. 3D-Printed Stents: With advancements in 3D printing technology, custom-made stents tailored to the unique anatomy of patients are becoming a possibility. This is particularly useful in complex cases where standard stents might not be effective.

Impact of COVID-19

The COVID-19 pandemic had a significant impact on the vascular stents market. During the height of the pandemic, elective surgeries were postponed, and the healthcare system focused on managing COVID-19 cases. This resulted in a temporary decline in the number of stent procedures performed. However, with the gradual reopening of healthcare services and the increasing emphasis on cardiovascular care, the market has begun to recover.

Moreover, the pandemic has highlighted the need for improving cardiovascular healthcare infrastructure, especially in developing regions, further driving the demand for vascular stents in the long term.

Frequently Asked Questions (FAQs)

1. What are vascular stents?
   Vascular stents are small mesh-like devices used to treat narrowed or blocked arteries. They help maintain blood flow in affected vessels and are commonly used in coronary artery disease, peripheral artery disease, and carotid artery disease.

2. What is the difference between bare-metal stents and drug-eluting stents?
   Bare-metal stents (BMS) are made from metal and are the traditional form of stent. Drug-eluting stents (DES) are coated with medication that helps prevent the re-narrowing of arteries by inhibiting the growth of scar tissue.

3. How do bioresorbable stents work?
   Bioresorbable stents are designed to dissolve after they have supported the artery long enough to restore blood flow. They are being developed as an alternative to traditional metal stents, potentially reducing the risk of long-term complications.

4. What is the expected growth rate of the vascular stents market?
   The vascular stents market is expected to grow at a CAGR of 5.5% from 2024 to 2032, reaching a value of nearly USD 17.10 billion by 2032.

5. Which region leads the vascular stents market?
   North America currently leads the vascular stents market due to advanced healthcare infrastructure, high adoption of medical technologies, and a large patient base.

6. How has COVID-19 impacted the vascular stents market?
   The COVID-19 pandemic temporarily slowed the growth of the vascular stents market, with delays in elective surgeries. However, the market is recovering as healthcare services resume, and the demand for cardiovascular care increases.